echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Lusheng and AstraZeneca reached a strategic cooperation to jointly promote ovarian cancer HRD detection in Southeast Asia

    Lusheng and AstraZeneca reached a strategic cooperation to jointly promote ovarian cancer HRD detection in Southeast Asia

    • Last Update: 2022-02-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    SINGAPORE, Nov.


    In 2020, the incidence of ovarian cancer in Asia accounted for more than half (54.


    About one in two patients with advanced ovarian cancer is HRD-positive


    AstraZeneca has been actively developing medical innovation partnerships and has launched the A.


    Vinod Narayanan, President of AstraZeneca Singapore, said: "Our partnership with Luson underscores AstraZeneca's continued drive to combine the expertise of medical technology innovators to help patients with chronic conditions including diabetes, heart disease and cancer


    "We are delighted to offer this test to cancer patients and doctors in Southeast Asia," said Dr.


    About AstraZeneca

    AstraZeneca is a science-first global biopharmaceutical company focused on the research and development, production and marketing of prescription medicines, with a focus on three major disease areas: oncology, cardiovascular, renal and metabolic, respiratory and immune


    About Lusheng

    Lusheng is a precision medicine company developing and applying ultra-sensitive liquid biopsy technology to enable early cancer detection and improve treatment options


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.